Earlier this month, Valencell announced its licensable fitness sensor technology has reached key milestones, achieving unprecedented validation by an independent study recently presented at the American College of Sports Medicine (ACSM) annual conference and validation testing supported by a National Institute of Health (NIH) Phase II Small Business Innovation Research (SBIR) program.